Vanguard Group Inc Tff Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.31 - $0.48 $2,101 - $3,253	-6,779 Reduced 0.79%	846,884 $296,000
Q2 2023 Aug 14, 2023	SELL	$0.43 - $0.77 $2,487 - $4,455	-5,786 Reduced 0.67%	853,663 $401,000
Q4 2022 Feb 10, 2023	SELL	$0.84 - $2.66 $7,544 - $23,892	-8,982 Reduced 1.03%	859,449 $902,000
Q2 2022 Aug 12, 2022	BUY	$3.99 - $7.22 $13,757 - $24,894	3,448 Added 0.4%	868,431 $4.91 Million
Q1 2022 May 13, 2022	BUY	$5.28 - $9.17 $278,852 - $484,295	52,813 Added 6.5%	864,983 $5.46 Million

Q4 2021 Feb 14, 2022	BUY	$6.86 - $9.65 $117,525 - $165,323	17,132 Added 2.15%	812,170 $7.2 Million
Q3 2021 Nov 12, 2021	BUY	$7.21 - $10.49 $167,156 - $243,200	23,184 Added 3.0%	795,038 $6.14 Million
Q2 2021 Aug 13, 2021	BUY	$8.48 - $13.61 $6.55 Million - $10.5 Million	771,854 New	771,854 $7.42 Million

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $45.4M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.